The −174 G/C Polymorphism in Interleukin-6 (IL-6) Promoter Region is Associated with Serum IL-6 and Carcinoembryonic Antigen Levels in Patients with Colorectal Cancers in Taiwan

[1] Chang KT(2005)Role of IL-6 in neuroendocrine differentiation and chemosensitivity of non-small cell lung cancer Am J Physiol Lung Cell Mol Physiol 289 L438-undefined

[2] Huang CY(2005)IL-6 induces neuroendocrine dedifferentiation and cell proliferation in non-small cell lung cancer cells Am J Physiol Lung Cell Mol Physiol 289 L446-undefined

[3] Tsai CM(2004)Correlation between interleukin 6 production and tumor proliferation in non-small cell lung cancer Cancer Immunol Immunother 53 786-undefined

[4] Chiu CH(2001)Plasma levels of interleukin-6 and its soluble receptor are associated with prostate cancer progression and metastasis Urology 58 1008-undefined

[5] Lok YY(2000)Biochemical markers of bone metabolism reflect osteoclastic and osteoblastic activity in multiple myeloma Eur J Haematol 64 121-undefined

[6] Chang KT(1998)Marked elevation of serum interleukin-6 in patients with cholangiocarcinoma: validation of utility as a clinical marker Ann Surg 227 398-undefined

[7] Tsai CM(1988)Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas Nature 332 83-undefined

[8] Chiou YC(1995)Prognostic significance of interleukin 6 serum levels in patients with ovarian cancer Br J Cancer 71 354-undefined

[9] Chiu CH(1996)Endogenous interleukin 6 can function as an in vivo growth-stimulatory factor for advanced-stage human melanoma cells Clin Cancer Res 2 1417-undefined

[10] Jeng KS(1995)Serum levels of interleukin 6 in patients with lung cancer Br J Cancer 71 1095-undefined

[1] Chang KT(2005)Role of IL-6 in neuroendocrine differentiation and chemosensitivity of non-small cell lung cancer Am J Physiol Lung Cell Mol Physiol 289 L438-undefined

[2] Huang CY(2005)IL-6 induces neuroendocrine dedifferentiation and cell proliferation in non-small cell lung cancer cells Am J Physiol Lung Cell Mol Physiol 289 L446-undefined

[3] Tsai CM(2004)Correlation between interleukin 6 production and tumor proliferation in non-small cell lung cancer Cancer Immunol Immunother 53 786-undefined

[4] Chiu CH(2001)Plasma levels of interleukin-6 and its soluble receptor are associated with prostate cancer progression and metastasis Urology 58 1008-undefined

[5] Lok YY(2000)Biochemical markers of bone metabolism reflect osteoclastic and osteoblastic activity in multiple myeloma Eur J Haematol 64 121-undefined

[6] Chang KT(1998)Marked elevation of serum interleukin-6 in patients with cholangiocarcinoma: validation of utility as a clinical marker Ann Surg 227 398-undefined

[7] Tsai CM(1988)Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas Nature 332 83-undefined

[8] Chiou YC(1995)Prognostic significance of interleukin 6 serum levels in patients with ovarian cancer Br J Cancer 71 354-undefined

[9] Chiu CH(1996)Endogenous interleukin 6 can function as an in vivo growth-stimulatory factor for advanced-stage human melanoma cells Clin Cancer Res 2 1417-undefined

[10] Jeng KS(1995)Serum levels of interleukin 6 in patients with lung cancer Br J Cancer 71 1095-undefined